GSK logo

GSK (GSK) Net income

annual net income:

$3.29B-$2.84B(-46.33%)
December 1, 2024

Summary

  • As of today (April 16, 2025), GSK annual net profit is $3.29 billion, with the most recent change of -$2.84 billion (-46.33%) on December 1, 2024.
  • During the last 3 years, GSK annual net income has fallen by -$2.74 billion (-45.45%).
  • GSK annual net income is now -82.23% below its all-time high of $18.52 billion, reached on December 31, 2022.

Performance

GSK Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGSKincome statement metrics

quarterly net income:

$530.05M+$605.52M(+802.32%)
December 1, 2024

Summary

  • As of today (April 16, 2025), GSK quarterly net profit is $530.05 million, with the most recent change of +$605.52 million (+802.32%) on December 1, 2024.
  • Over the past year, GSK quarterly net income has stayed the same.
  • GSK quarterly net income is now -95.84% below its all-time high of $12.74 billion, reached on September 30, 2022.

Performance

GSK quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGSKincome statement metrics

TTM net income:

$3.26B+$95.36M(+3.01%)
December 1, 2024

Summary

  • As of today (April 16, 2025), GSK TTM net profit is $3.26 billion, with the most recent change of +$95.36 million (+3.01%) on December 1, 2024.
  • Over the past year, GSK TTM net income has stayed the same.
  • GSK TTM net income is now -82.21% below its all-time high of $18.34 billion, reached on June 30, 2023.

Performance

GSK TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGSKincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

GSK Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-46.3%0.0%0.0%
3 y3 years-45.5%-78.1%-50.2%
5 y5 years-44.5%-78.1%-50.2%

GSK Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-82.2%at low-95.8%+802.3%-82.2%+3.0%
5 y5-year-82.2%at low-95.8%+802.3%-82.2%+3.0%
alltimeall time-82.2%+471.3%-95.8%+148.6%-82.2%+4217.0%

GSK Net income History

DateAnnualQuarterlyTTM
Dec 2024
$3.29B(-46.3%)
$530.05M(-802.3%)
$3.26B(+3.0%)
Sep 2024
-
-$75.47M(-105.1%)
$3.17B(-37.9%)
Jun 2024
-
$1.48B(+11.5%)
$5.10B(-9.8%)
Mar 2024
-
$1.33B(+205.2%)
$5.65B(-7.9%)
Dec 2023
$6.13B(-66.9%)
$434.69M(-76.6%)
$6.13B(-17.7%)
Sep 2023
-
$1.85B(-8.8%)
$7.46B(-59.3%)
Jun 2023
-
$2.03B(+12.2%)
$18.34B(+5.6%)
Mar 2023
-
$1.81B(+3.0%)
$17.36B(-3.4%)
Dec 2022
$18.52B(+207.0%)
$1.76B(-86.2%)
$17.96B(+8.9%)
Sep 2022
-
$12.74B(+1108.9%)
$16.50B(+191.9%)
Jun 2022
-
$1.05B(-56.4%)
$5.65B(-13.7%)
Mar 2022
-
$2.42B(+718.9%)
$6.55B(+16.7%)
Dec 2021
$6.03B(-18.2%)
$295.22M(-84.3%)
$5.61B(-9.6%)
Sep 2021
-
$1.89B(-3.3%)
$6.21B(+4.7%)
Jun 2021
-
$1.95B(+31.8%)
$5.93B(-12.6%)
Mar 2021
-
$1.48B(+65.6%)
$6.79B(-7.2%)
Dec 2020
$7.38B(+24.4%)
$893.26M(-44.4%)
$7.31B(-9.6%)
Sep 2020
-
$1.61B(-42.7%)
$8.09B(-3.6%)
Jun 2020
-
$2.81B(+39.9%)
$8.40B(+22.9%)
Mar 2020
-
$2.01B(+19.9%)
$6.83B(+15.7%)
Dec 2019
$5.93B(+22.7%)
$1.67B(-12.5%)
$5.91B(+1.9%)
Sep 2019
-
$1.91B(+54.4%)
$5.80B(+1.1%)
Jun 2019
-
$1.24B(+14.6%)
$5.73B(+12.5%)
Mar 2019
-
$1.08B(-30.8%)
$5.09B(+6.7%)
Dec 2018
$4.83B(+144.4%)
$1.56B(-15.4%)
$4.77B(+92.0%)
Sep 2018
-
$1.85B(+207.4%)
$2.49B(+11.7%)
Jun 2018
-
$600.96M(-21.3%)
$2.23B(+59.6%)
Mar 2018
-
$763.39M(-205.3%)
$1.39B(-27.6%)
Dec 2017
$1.98B(+60.1%)
-$725.04M(-145.7%)
$1.93B(-35.1%)
Sep 2017
-
$1.59B(-789.5%)
$2.97B(+21.5%)
Jun 2017
-
-$230.10M(-117.8%)
$2.45B(+19.2%)
Mar 2017
-
$1.30B(+305.8%)
$2.05B(+76.9%)
Dec 2016
$1.24B(-90.4%)
$319.24M(-69.9%)
$1.16B(+282.4%)
Sep 2016
-
$1.06B(-269.9%)
$303.21M(+301.4%)
Jun 2016
-
-$624.85M(-254.8%)
$75.54M(-91.9%)
Mar 2016
-
$403.69M(-175.2%)
$928.63M(-92.7%)
Dec 2015
$12.87B(+183.3%)
-$536.96M(-164.4%)
$12.79B(-14.5%)
Sep 2015
-
$833.66M(+265.3%)
$14.96B(+1.1%)
Jun 2015
-
$228.23M(-98.1%)
$14.79B(-5.6%)
Mar 2015
-
$12.26B(+650.3%)
$15.67B(+247.4%)
Dec 2014
$4.54B(-46.6%)
$1.63B(+144.1%)
$4.51B(-34.3%)
Sep 2014
-
$669.49M(-39.2%)
$6.86B(-10.8%)
Jun 2014
-
$1.10B(-0.4%)
$7.69B(-6.2%)
Mar 2014
-
$1.11B(-72.3%)
$8.20B(-4.5%)
Dec 2013
$8.51B(+19.3%)
$3.98B(+165.1%)
$8.58B(+44.0%)
Sep 2013
-
$1.50B(-6.4%)
$5.96B(-3.9%)
Jun 2013
-
$1.61B(+7.5%)
$6.20B(-5.4%)
Mar 2013
-
$1.49B(+9.7%)
$6.56B(-7.9%)
Dec 2012
$7.13B(-15.5%)
$1.36B(-22.0%)
$7.12B(-7.8%)
Sep 2012
-
$1.74B(-11.0%)
$7.73B(-5.8%)
Jun 2012
-
$1.96B(-4.6%)
$8.20B(+1.9%)
Mar 2012
-
$2.05B(+4.4%)
$8.05B(-4.6%)
Dec 2011
$8.44B(+234.9%)
$1.97B(-11.3%)
$8.43B(+56.9%)
Sep 2011
-
$2.22B(+23.0%)
$5.38B(+4.3%)
Jun 2011
-
$1.80B(-26.1%)
$5.15B(+78.0%)
Mar 2011
-
$2.44B(-324.1%)
$2.90B(+13.9%)
Dec 2010
$2.52B(-70.9%)
-$1.09B(-154.6%)
$2.54B(-59.6%)
Sep 2010
-
$2.00B(-540.3%)
$6.29B(-3.0%)
Jun 2010
-
-$453.16M(-121.7%)
$6.49B(-29.2%)
Mar 2010
-
$2.09B(-21.5%)
$9.17B(+5.3%)
Dec 2009
$8.66B(+1.8%)
$2.66B(+21.6%)
$8.71B(+14.9%)
Sep 2009
-
$2.19B(-1.8%)
$7.58B(+3.4%)
Jun 2009
-
$2.23B(+37.2%)
$7.33B(-4.0%)
Mar 2009
-
$1.63B(+5.8%)
$7.64B(-11.2%)
Dec 2008
$8.51B(-18.5%)
$1.54B(-20.9%)
$8.60B(-6.9%)
Sep 2008
-
$1.94B(-23.4%)
$9.23B(-7.1%)
Jun 2008
-
$2.54B(-1.9%)
$9.94B(-1.1%)
Mar 2008
-
$2.58B(+19.0%)
$10.05B(-3.6%)
Dec 2007
$10.45B(+5.2%)
$2.17B(-18.0%)
$10.43B(-0.8%)
Sep 2007
-
$2.65B(+0.0%)
$10.52B(+0.4%)
Jun 2007
-
$2.65B(-10.6%)
$10.47B(+2.4%)
Mar 2007
-
$2.96B(+30.9%)
$10.23B(+3.3%)
Dec 2006
$9.93B(+16.5%)
$2.26B(-13.2%)
$9.90B(+3.2%)
Sep 2006
-
$2.61B(+8.3%)
$9.60B(+5.9%)
Jun 2006
-
$2.41B(-8.5%)
$9.06B(+2.3%)
Mar 2006
-
$2.63B(+34.3%)
$8.86B(+4.2%)
Dec 2005
$8.53B
$1.96B(-5.3%)
$8.50B(+6.5%)
Sep 2005
-
$2.07B(-6.1%)
$7.99B(+3.0%)
Jun 2005
-
$2.20B(-3.1%)
$7.75B(+3.1%)
DateAnnualQuarterlyTTM
Mar 2005
-
$2.27B(+57.8%)
$7.52B(+5.1%)
Dec 2004
$7.16B(-2.2%)
$1.44B(-21.5%)
$7.15B(+1.5%)
Sep 2004
-
$1.84B(-6.7%)
$7.04B(-0.5%)
Jun 2004
-
$1.97B(+3.3%)
$7.08B(-2.4%)
Mar 2004
-
$1.91B(+42.5%)
$7.26B(-0.5%)
Dec 2003
$7.32B(+23.8%)
$1.34B(-28.7%)
$7.29B(-1.9%)
Sep 2003
-
$1.87B(-12.4%)
$7.43B(+9.6%)
Jun 2003
-
$2.14B(+10.3%)
$6.78B(+6.5%)
Mar 2003
-
$1.94B(+31.4%)
$6.37B(+8.1%)
Dec 2002
$5.91B(+32.5%)
$1.48B(+20.7%)
$5.89B(+0.7%)
Sep 2002
-
$1.22B(-29.0%)
$5.85B(+13.2%)
Jun 2002
-
$1.72B(+17.8%)
$5.17B(+5.4%)
Mar 2002
-
$1.46B(+2.0%)
$4.90B(+9.9%)
Dec 2001
$4.46B(-29.2%)
$1.43B(+163.9%)
$4.46B(-19.6%)
Sep 2001
-
$543.60M(-62.8%)
$5.55B(-9.2%)
Jun 2001
-
$1.46B(+42.8%)
$6.11B(+1.9%)
Mar 2001
-
$1.02B(-59.5%)
$6.00B(-4.0%)
Dec 2000
$6.31B(+115.3%)
$2.52B(+128.0%)
$6.25B(+39.6%)
Sep 2000
-
$1.11B(-17.9%)
$4.47B(+9.0%)
Jun 2000
-
$1.35B(+5.7%)
$4.10B(+16.4%)
Mar 2000
-
$1.27B(+70.1%)
$3.53B(+17.6%)
Dec 1999
$2.93B(-3.7%)
$748.61M(+1.9%)
$3.00B(-3.2%)
Sep 1999
-
$734.58M(-4.5%)
$3.10B(-3.1%)
Jun 1999
-
$769.18M(+3.1%)
$3.20B(+2.8%)
Mar 1999
-
$746.03M(-12.0%)
$3.11B(+2.2%)
Dec 1998
$3.04B(+0.4%)
$847.33M(+1.7%)
$3.04B(+7.6%)
Sep 1998
-
$833.17M(+21.9%)
$2.83B(+5.8%)
Jun 1998
-
$683.47M(+0.5%)
$2.67B(-5.4%)
Mar 1998
-
$680.26M(+7.8%)
$2.83B(-5.6%)
Dec 1997
$3.03B(-2.8%)
$631.02M(-7.1%)
$3.00B(-20.1%)
Sep 1997
-
$678.89M(-18.9%)
$3.75B(+15.3%)
Jun 1997
-
$836.67M(-1.4%)
$3.25B(+1.3%)
Mar 1997
-
$848.90M(-38.8%)
$3.21B(+1.2%)
Dec 1996
$3.12B(+35.5%)
$1.39B(+664.6%)
$3.17B(+77.5%)
Sep 1996
-
$181.27M(-77.2%)
$1.79B(-11.4%)
Jun 1996
-
$794.63M(-2.1%)
$2.02B(+21.9%)
Mar 1996
-
$811.76M(+97.4%)
$1.65B(-0.8%)
Dec 1995
$2.30B(+40.3%)
-
-
Sep 1995
-
$411.31M(-4.8%)
$1.67B(+0.3%)
Jun 1995
-
$431.87M(+6.5%)
$1.66B(+2.0%)
Jun 1995
$1.64B(-15.6%)
-
-
Mar 1995
-
$405.61M(-3.3%)
$1.63B(-3.9%)
Dec 1994
-
$419.37M(+3.3%)
$1.70B(-6.5%)
Sep 1994
-
$405.93M(+1.7%)
$1.81B(-6.5%)
Jun 1994
$1.94B(-0.9%)
$399.24M(-15.4%)
$1.94B(+0.4%)
Mar 1994
-
$471.74M(-12.3%)
$1.93B(-2.8%)
Dec 1993
-
$537.98M(+1.3%)
$1.99B(+4.0%)
Sep 1993
-
$531.29M(+35.4%)
$1.91B(+3.0%)
Jun 1993
$1.96B(+8.0%)
$392.26M(-25.6%)
$1.86B(+3.1%)
Mar 1993
-
$526.93M(+14.0%)
$1.80B(+1.5%)
Dec 1992
-
$462.18M(-2.9%)
$1.77B(-0.2%)
Sep 1992
-
$475.77M(+41.8%)
$1.78B(+0.2%)
Jun 1992
$1.82B(+11.2%)
$335.55M(-32.9%)
$1.77B(-7.9%)
Mar 1992
-
$499.82M(+7.2%)
$1.93B(+5.1%)
Dec 1991
-
$466.37M(-1.3%)
$1.83B(+5.3%)
Sep 1991
-
$472.50M(-3.0%)
$1.74B(+6.4%)
Jun 1991
$1.63B(+24.5%)
$487.06M(+19.9%)
$1.63B(+10.3%)
Mar 1991
-
$406.21M(+8.7%)
$1.48B(+3.0%)
Dec 1990
-
$373.54M(+1.5%)
$1.44B(+3.2%)
Sep 1990
-
$367.88M(+9.8%)
$1.40B(+3.0%)
Jun 1990
$1.31B(+11.2%)
$334.99M(-7.8%)
$1.35B(+0.2%)
Mar 1990
-
$363.21M(+10.4%)
$1.35B(+8.6%)
Dec 1989
-
$328.94M(+0.5%)
$1.25B(+3.7%)
Sep 1989
-
$327.45M(-1.5%)
$1.20B(+3.4%)
Jun 1989
$1.18B(+15.9%)
$332.29M(+29.5%)
$1.16B(+0.5%)
Mar 1989
-
$256.54M(-10.0%)
$1.16B(+2.6%)
Dec 1988
-
$284.94M(-1.1%)
$1.13B(+4.3%)
Sep 1988
-
$288.18M(-11.6%)
$1.08B(+3.5%)
Jun 1988
$1.02B(+31.0%)
$325.99M(+43.7%)
$1.04B(+10.2%)
Mar 1988
-
$226.85M(-4.8%)
$947.03M(+1.4%)
Dec 1987
-
$238.18M(-5.5%)
$933.59M(+7.6%)
Sep 1987
-
$252.17M(+9.7%)
$868.04M(+8.6%)
Jun 1987
$777.81M(+35.0%)
$229.83M(+7.7%)
$799.51M(+14.0%)
Mar 1987
-
$213.41M(+23.6%)
$701.22M(+9.6%)
Dec 1986
-
$172.64M(-6.0%)
$639.66M(+3.1%)
Sep 1986
-
$183.63M(+39.6%)
$620.56M(+5.5%)
Jun 1986
$576.08M
$131.55M(-13.4%)
$588.32M(+28.8%)
Mar 1986
-
$151.84M(-1.1%)
$456.77M(+49.8%)
Dec 1985
-
$153.54M(+1.4%)
$304.93M(+101.4%)
Sep 1985
-
$151.39M
$151.39M

FAQ

  • What is GSK annual net profit?
  • What is the all time high annual net income for GSK?
  • What is GSK annual net income year-on-year change?
  • What is GSK quarterly net profit?
  • What is the all time high quarterly net income for GSK?
  • What is GSK quarterly net income year-on-year change?
  • What is GSK TTM net profit?
  • What is the all time high TTM net income for GSK?
  • What is GSK TTM net income year-on-year change?

What is GSK annual net profit?

The current annual net income of GSK is $3.29B

What is the all time high annual net income for GSK?

GSK all-time high annual net profit is $18.52B

What is GSK annual net income year-on-year change?

Over the past year, GSK annual net profit has changed by -$2.84B (-46.33%)

What is GSK quarterly net profit?

The current quarterly net income of GSK is $530.05M

What is the all time high quarterly net income for GSK?

GSK all-time high quarterly net profit is $12.74B

What is GSK quarterly net income year-on-year change?

Over the past year, GSK quarterly net profit has changed by $0.00 (0.00%)

What is GSK TTM net profit?

The current TTM net income of GSK is $3.26B

What is the all time high TTM net income for GSK?

GSK all-time high TTM net profit is $18.34B

What is GSK TTM net income year-on-year change?

Over the past year, GSK TTM net profit has changed by $0.00 (0.00%)
On this page